Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010483
Filing Date
2020-08-13
Accepted
2020-08-13 07:17:47
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akus-20200630x10q.htm 10-Q 1525041
2 EX-31.1 akus-20200630ex3116ef72b.htm EX-31.1 15403
3 EX-32.1 akus-20200630ex321b4ea2c.htm EX-32.1 9610
  Complete submission text file 0001558370-20-010483.txt   5319808

Data Files

Seq Description Document Type Size
4 EX-101.INS akus-20200630.xml EX-101.INS 1031551
5 EX-101.SCH akus-20200630.xsd EX-101.SCH 33520
6 EX-101.CAL akus-20200630_cal.xml EX-101.CAL 34360
7 EX-101.DEF akus-20200630_def.xml EX-101.DEF 131048
8 EX-101.LAB akus-20200630_lab.xml EX-101.LAB 352973
9 EX-101.PRE akus-20200630_pre.xml EX-101.PRE 269394
Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-245-5715
Akouos, Inc. (Filer) CIK: 0001722271 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39343 | Film No.: 201097200
SIC: 2834 Pharmaceutical Preparations